Results 191 to 200 of about 16,223 (208)

Progressive supranuclear palsy

2011
Andrew E. Budson, Paul R. Solomon
openaire   +1 more source

Naloxone in Progressive Supranuclear Palsy

Clinical Neuropharmacology, 1985
R, Sandyk, S R, Snider
openaire   +2 more sources

Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy

Brain, 2010
Richard G Brown, Thomas Bak, Ingo Uttner   +2 more
exaly  

Progressive Supranuclear Palsy

Seminars in Neurology, 2014
Lawrence Golbe
exaly  

Predictors of survival in a series of clinically diagnosed progressive supranuclear palsy patients

Parkinsonism and Related Disorders, 2013
Giancarlo Logroscino, Paolo Lamberti
exaly  

Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia

Acta Neuropathologica, 2017
Dennis W Dickson, Jennifer Yokoyama, Leo Sugrue   +2 more
exaly  

Methysergide in progressive supranuclear palsy

Neurology, 1985
A S, Duncombe, A J, Lees
openaire   +2 more sources

Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease

Brain, 2012
Andrew John Lees, Peter Brown, Helen Ling   +2 more
exaly  

[18F]AV‐1451 tau positron emission tomography in progressive supranuclear palsy

Movement Disorders, 2017
Jennifer Whitwell, Clifford R Jack, M L Senjem   +2 more
exaly  

Pharmacological Therapy in Progressive Supranuclear Palsy

Archives of Neurology, 1998
Christopher Goetz, I Litvan, M Verny
exaly